Tesamorelin
Key Takeaways: Tesamorelin
Tesamorelin is a GHRH peptide primarily researched for:
- Potent reduction of visceral fat
- Increased lean body mass
- Improved cognitive function
Research Profile
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog specifically designed to target visceral adipose tissue (VAT), the dangerous fat accumulated around internal organs.
Specialized Fat Loss
Tesamorelin is FDA-approved for reducing abdominal fat in patients with HIV-associated lipodystrophy. It is highly effective at reducing the “hard” belly fat that is resistant to diet and exercise, without impacting healthy subcutaneous fat.
Brain Health
Emerging research suggests that Tesamorelin may also provide neuroprotective benefits, improving executive function and memory in older adults at risk for cognitive decline, possibly due to the specialized way it pulses growth hormone in the brain.
Clinical Data & Studies
Key Benefits
- Potent reduction of visceral fat
- Increased lean body mass
- Improved cognitive function
- Enhanced GH levels
Potential Side Effects
- Injection site reactions
- Muscle pain
Stability Profile
Stable for 4-6 weeks
Relatively stable for 7 days
Related Peptides in GHRH Family
CJC-1295 (No DAC)
Reconstitute with Bacteriostatic Water. 2-3mL per 5mg vial is common. Swirl gently; avoid shaking.
CJC-1295 (With DAC)
Reconstitute with Bacteriostatic Water. 2-3mL per 5mg vial is common.
Sermorelin
Reconstitute with Bacteriostatic Water. 3mL for 10mg recommended.